Invention Grant
- Patent Title: Crystallizing method of erythromycin
- Patent Title (中): 红霉素的结晶方法
-
Application No.: US13063933Application Date: 2009-10-29
-
Publication No.: US08436154B2Publication Date: 2013-05-07
- Inventor: Xiaoping Ma , Luning Song
- Applicant: Xiaoping Ma , Luning Song
- Applicant Address: CN Northern Industrial Area, Songshan Lake, Dongguan, Guangdong
- Assignee: Sunshine Lake Pharma Co., Ltd.
- Current Assignee: Sunshine Lake Pharma Co., Ltd.
- Current Assignee Address: CN Northern Industrial Area, Songshan Lake, Dongguan, Guangdong
- Agency: Squire Sanders
- Agent Kam W. Law
- Priority: CN200810225310 20081029
- International Application: PCT/CN2009/001204 WO 20091029
- International Announcement: WO2010/048786 WO 20100506
- Main IPC: C07H17/08
- IPC: C07H17/08

Abstract:
The present invention provides an erythromycin crystallizing method, which comprises using dichloromethane containing solvent as a preparation solvent, and the dichloromethane solution of erythromycin received was gradiently cooled from high temperature down to low temperature, and thus making erythromycin crystallize. According to the method of the present invention, the content of erythromycin A is high, the content of erythromycin A in the erythromycin crystalline is more than 94.5% (HPLC detection method), the content of dichloromethane in the erythromycin crystalline is less than 600 ppm, the content of water in the erythromycin crystalline is less than 2.5%, the microbiological titre of the erythromycin crystalline is more than 940 μ/mg.
Public/Granted literature
- US20110172402A1 CRYSTALLIZING METHOD OF ERYTHROMYCIN Public/Granted day:2011-07-14
Information query